Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis
Whether youre exploring medication options or need help fine-tuning your current plan, were here for you
Disclosures: Xiaoli Liu: Nothing to Disclose, Huiwen Yan: Nothing to Disclose, Lihua Yu: Nothing to Disclose, Yixin Hou: Nothing to Disclose, Tingting Jiang: Nothing to Disclose, Xianbo Wang: Nothing to Disclose, Jiang Yuyong: Nothing to Disclose, Yaxian Kong: Nothing to Disclose, Zhiyun Yang: Nothing to Disclose 1951 SARCOPENIA IMPACTS TREATMENT TOLERANCE AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN CIRRHOSIS Krishnadas Devadas 1 Akhil Visruthakumar 2 , 1 Government Medical College, Thiruvananthapuram, 2 Government Medical College, Trivandrum Background: Hepatocellular carcinoma(HCC) is the most common primary liver malignancy and the third leading cause of cancer-related mortality worldwide
10.2147/IJN.S496982 [DOI] [PMC free article] [PubMed] 165.Jiang Z, et al
Get the details in our Protein Powders Review + see our Top Picks among protein powders
[1] [2] Common GLP-1 medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist
